Patent US4080471A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4080471A Expired / Lapsed US ⏱️ 0.0 years remaining

Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart

Assignee: AstraZeneca AB
•
Filing: 1976-06-25
•
Granted: 1978-03-21
•
Expires: 1996-06-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for inducing increased inotropic effects of the human heart without inducing arrhythmogenic effects, but providing an antiarrhythmogenic effect therein. The method is effected by administering to mammals, including man, a compound of the formula ##STR1## wherein R is selected from the group consisting of hydrogen or ##STR2## wherein R' is selected from the group consisting of straight or branched aliphatic alkyl having 1 to 7 carbon atoms, phenyl, benzyl, and phenylethyl, wherein the phenyl nucleus may be further substituted with alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, alkoxyalkyl having 2 to 8 carbon atoms or halogen, in any position.

Inventors

  • 👤 Enar Ingemar Carlsson
  • 👤 Nils Henry Alfons Persson
  • 👤 Gustav Benny Roger Samuelsson
  • 👤 Kjell Ingvar Leopold Wetterlin

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 19:51
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/13; A61K31/135; A61K31/21; A61K31/215; A61K31/22; A61K31/23; A61K31/235

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 119 words
The method of inducing increased inotropic effects of the human heart without inducing arrhythmogenic effects but providing an antiarrhythmogenic effect therein by administering to humans, suffering from too low heart inotropy in an amount sufficient to induce increased inotropic effects of the heart, a compound of the formula ##STR5## wherein R is selected from the group consisting of hydrogen or ##STR6## wherein R' is selected from the group consisting of straight or branched aliphatic alkyl having 1 to 7 carbon atoms, phenyl, benzyl, and phenylethyl, wherein the phenyl nucleus may be further substituted with alkyl having 1 to 4 carbon atoms, alkoxyalkyl having 2 to 8 carbon atoms or halogen, in any position, or a therapeutically acceptable salt thereof.
Claim 2
Independent Claim 119 words
The method of inducing increased inotropic effects of the human heart without inducing arrhythmogenic effects but providing an antiarrhythmogenic effect therein by administering to humans, suffering from too low heart inotropy in an amount sufficient to induce increased inotropic effects of the heart, a compound of the formula ##STR5## wherein R is selected from the group consisting of hydrogen or ##STR6## wherein R' is selected from the group consisting of straight or branched aliphatic alkyl having 1 to 7 carbon atoms, phenyl, benzyl, and phenylethyl, wherein the phenyl nucleus may be further substituted with alkyl having 1 to 4 carbon atoms, alkoxyalkyl having 2 to 8 carbon atoms or halogen, in any position, or a therapeutically acceptable salt thereof.
Claim 3
Dependent Claim 16 words
The method according to claim 1, wherein 1-isopropylamino-3-(p-hydroxyphenoxy)-propanol-2, or a therapeutically acceptable salt thereof is administered.
Claim 4
Dependent Claim 16 words
The method according to claim 1, wherein 1-isopropylamino-3-(p-isobutyryloxyphenoxy)-propanol-2 or a therapeutically acceptable salt thereof is administered.
Claim 5
Dependent Claim 16 words
The method according to claim 1, wherein 1-isopropylamino-3-(p-benzoyloxyphenoxy)-propanol-2 or a therapeutically acceptable salt thereof is administered.
Claim 6
Dependent Claim 16 words
The method according to claim 1, wherein 1-isopropylamino-3-(p-pivaloyloxyphenoxy)-propanol-2 or a therapeutically acceptable salt thereof is administered.

References Cited (Backward Citations)

US3501769A Cited
GB1069345A Cited
US3740443A Cited
US3857891A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-03-20 1981-09-19 1982-03-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-03-20 1985-09-19 1986-03-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-03-20 1989-09-19 1990-03-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag